Cargando…

Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review

There is an unmet need for novel non-invasive prognostic molecular tumour markers for breast cancer (BC). Accumulating evidence shows that miR-155 plays a pivotal role in tumorigenesis. Generally, miR-155 is considered an oncogenic miRNA promoting tumour growth, angiogenesis and aggressiveness of BC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimaldi, Anna Maria, Nuzzo, Silvia, Condorelli, Gerolama, Salvatore, Marco, Incoronato, Mariarosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461504/ https://www.ncbi.nlm.nih.gov/pubmed/32823863 http://dx.doi.org/10.3390/ijms21165834

Ejemplares similares

Epigenetic Regulation of miR-212 Expression in Lung Cancer
por: Incoronato, Mariarosaria, et al.
Publicado: (2011)

Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis
por: Tang, Lu, et al.
Publicado: (2019)

miRNA-Based Therapeutics in Breast Cancer: A Systematic Review
por: Grimaldi, Anna Maria, et al.
Publicado: (2021)

miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer
por: Fernandez, Serena, et al.
Publicado: (2014)

Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis
por: ZHENG, SHU-RONG, et al.
Publicado: (2012)

Clinical Translatability of “Identified” Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update
por: Grimaldi, Anna Maria, et al.
Publicado: (2019)

Antifouling Strategies of Nanoparticles for Diagnostic and Therapeutic Application: A Systematic Review of the Literature
por: Bevilacqua, Paolo, et al.
Publicado: (2021)

In silico recognition of a prognostic signature in basal-like breast cancer patients
por: Conte, Federica, et al.
Publicado: (2022)

Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance
por: Wang, Lingling, et al.
Publicado: (2016)

miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment
por: Roscigno, Giuseppina, et al.
Publicado: (2020)

miR-155 in the Resolution of Atherosclerosis
por: Bruen, Robyn, et al.
Publicado: (2019)

Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis
por: Hu, Lixia, et al.
Publicado: (2021)

Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review
por: Grimaldi, Anna Maria, et al.
Publicado: (2022)

Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer
por: Bašová, Petra, et al.
Publicado: (2017)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2020)

Effect of miR-146a and miR-155 on cardiac xenotransplantation
por: Zhao, Zhicheng, et al.
Publicado: (2016)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
por: López, Paulina, et al.
Publicado: (2018)

MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
por: Roscigno, Giuseppina, et al.
Publicado: (2017)

miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014)

The Clinicopathological Significance of miR-133a in Colorectal Cancer
por: Wan, Timothy Ming-Hun, et al.
Publicado: (2014)

MiR-155: An Important Regulator of Neuroinflammation
por: Zingale, Valeria Domenica, et al.
Publicado: (2021)

The Role of miR-155 in Antitumor Immunity
por: Kalkusova, Katerina, et al.
Publicado: (2022)

In vivo inhibition of miR-155 significantly alters post-stroke inflammatory response
por: Pena-Philippides, Juan Carlos, et al.
Publicado: (2016)

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma
por: Slezak-Prochazka, Izabella, et al.
Publicado: (2015)

Preparation of a miR-155-activating nucleic acid nanoflower to study the molecular mechanism of miR-155 in inflammation
por: Wang, Wenxin, et al.
Publicado: (2022)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma
por: Greither, Thomas, et al.
Publicado: (2020)

Involvement of miR-142 and miR-155 in Non-Infectious Complications of CVID
por: Amato, Giuliana, et al.
Publicado: (2020)

A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer
por: Han, Ji-Guang, et al.
Publicado: (2017)

Profiling Tissue and Biofluid miR-155-5p, miR-155(*), and miR-146a-5p Expression in Graft vs. Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2021)

miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase
por: Orlandella, Francesca Maria, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis
por: Zhang, Dan, et al.
Publicado: (2022)

Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
por: Russo, Valentina, et al.
Publicado: (2018)

The Clinicopathological Significance of MicroRNA-155 in Breast Cancer: A Meta-Analysis
por: Zeng, Hui, et al.
Publicado: (2014)

Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
por: Sochor, Marek, et al.
Publicado: (2014)

Peripheral blood mononuclear cells expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis
por: Saadatian, Zahra, et al.
Publicado: (2023)

Exosome-mediated breast cancer chemoresistance via miR-155 transfer
por: Santos, Juliana Carvalho, et al.
Publicado: (2018)

Predicting Survival in Glioblastoma Patients Using Diffusion MR Imaging Metrics—A Systematic Review
por: Brancato, Valentina, et al.
Publicado: (2020)

The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature
por: Nuzzo, Silvia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tlnc83gcf1ul6p2rcbq179ucbt